CINRYZE®* (C1 inhibitor [human]) now available in Canada
Bay Street
First and Only Treatment Approved in Canada for Routine Prevention of Attacks of a Rare Swelling Disorder
MONTRÉAL, March 23, 2016 /CNW Telbec/ – Shire Pharma Canada ULC (“Shire Canada”) today announced that CINRYZE is now available in Canada to patients with hereditary…